Roles of transforming growth factor-β signaling in liver disease

doi:10.4254/wjh.v16.i7.973

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=16

Jul 27, 2024 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hepatol. Jul 27, 2024; 16(7): 973-979
Published online Jul 27, 2024. doi: 10.4254/wjh.v16.i7.973

Roles of transforming growth factor-β signaling in liver disease

Xiao-Ling Wang, Meng Yang, Ying Wang

Xiao-Ling Wang, Meng Yang, Ying Wang, Clinical Laboratory, Shanxi Academy of Traditional Chinese Medicine, Taiyuan 030012, Shanxi Province, China

Author contributions: All authors participated in the discussion of the content of the article; The manuscript was written by Wang XL, Yang M and Wang Y; and all authors reviewed and edited the manuscript prior to submission.

Supported by Shanxi Provincial Health Commission Youth Research Project, No. 2021081; and Traditional Chinese Medicine Administration of Shanxi Province, No. 2023ZYYDA2001.

Conflict-of-interest statement: The authors declare having no conflict of interests.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Xiao-Ling Wang, PhD, Chief Technician, Clinical Laboratory, Shanxi Academy of Traditional Chinese Medicine, No. 46 Bingzhou West Street, Yingze District, Taiyuan 030012, Shanxi Province, China. wangxiaoling24@163.com

Received: December 28, 2023
Revised: March 4, 2024
Accepted: May 24, 2024
Published online: July 27, 2024
Processing time: 210 Days and 23.8 Hours

Core Tip

Core Tip: Transforming growth factor-β (TGF-β) participates in diverse signaling pathways and exhibits contradictory roles in liver immunity, inflammation, repair, fibrosis, and other biological processes. In this editorial, we review the evidence for potential TGF-β signaling pathway molecules as diagnostic or therapeutic targets for different liver disease stages.